Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Clinical trial NCT07157774 · RECRUITING

Trial details

NCT number: NCT07157774
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Elevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD)

Start date: 2025-09-02
Primary completion: 2031-03-01
Enrollment: 10450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.